SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                ----------------

                                  SCHEDULE 13G


             INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
          TO RULES 13-D(1)(B)(C), AND (D) AND AMENDMENTS THERETO FILED
                            PURSUANT TO RULE 13D-2(B)
                                (AMENDMENT NO. 7)


                                 CryoLife, Inc.
- --------------------------------------------------------------------------------
                                (Name of Issuer)


                          Common Stock, $0.01 par value
- --------------------------------------------------------------------------------
                         (Title and Class of Securities)


                                   228 903 100
- --------------------------------------------------------------------------------
                                 (CUSIP Number)


                                December 31, 2000
- --------------------------------------------------------------------------------
             (Date of Event Which Requires Filing of this Statement)


Check the  appropriate box to designate the rule pursuant to which this Schedule
is filed:

                        [ ]  Rule 13d-1(b)

                        [ ]  Rule 13d-1(c)

                        [X]  Rule 13d-1(d)



__________________

     (1) The  remainder  of this cover page shall be filled out for a  reporting
person's  initial  filing on this  form with  respect  to the  subject  class of
securities,  and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.

     The  information  required in the remainder of this cover page shall not be
deemed to be "filed"  for the purpose of Section 18 of the  Securities  Exchange
Act of 1934 or otherwise  subject to the  liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

                                       1


CUSIP NO. 228 903 100                                            13G
          -----------

(1)  Names of  Reporting  Persons  I.R.S.  Identification  No. of Above  Persons
     (Entities Only)

Steven G. Anderson, SS# ###-##-####
- --------------------------------------------------------------------------------

(2)  Check the Appropriate Box if a Member of a Group

     (a) __________.
     (b) __________.

- --------------------------------------------------------------------------------
(3) SEC Use Only

- --------------------------------------------------------------------------------
(4)         Citizenship or Place of Organization

United States
- --------------------------------------------------------------------------------

Number of         (5)    Sole Voting Power              1,590,468 (1)
Shares
Beneficially      (6)    Shared Voting Power              157,999 (2)
Owned by
Each              (7)    Sole Dispositive Power         1,590,468 (1)
Reporting
Person With       (8)    Shared Dispositive Power         157,999 (2)

(9)  Aggregate Amount Beneficially Owned by Each Reporting Person

     1,748,467
- --------------------------------------------------------------------------------

(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares ____.

- --------------------------------------------------------------------------------

(11) Percent of Class Represented by Amount in Row 9
     9.3 percent
- --------------------------------------------------------------------------------

(12) Type of Reporting Person

IN
- --------------------------------------------------------------------------------

(1)  Includes 18,300 shares of Common Stock which are issuable upon the exercise
     of stock options within 60 days of the date of this report.

(2)  Includes 157,999 shares owned by Mr. Anderson's spouse.

                                       2


CUSIP NO. 228 903 100                                          13G
          -----------

Item l(a). Name of Issuer:

           CryoLife, Inc.

Item l(b). Address of Issuer's Principal Executive Offices:

           1655 Roberts Boulevard
           Kennesaw, Georgia  30144

Item 2(a). Name of Person Filing:

           See item (l) of the cover pages

Item 2(b). Address of Principal Business Office:

           1655 Roberts Boulevard
           Kennesaw, Georgia  30144

Item 2(c). Citizenship:

           See  item (4) of cover pages

Item 2(d). Title of Class of Securities:

           Common Stock, $0.01 Par Value

Item 2(e). CUSIP Number:

           228 903 100

Item 3. Not applicable

Item 4. Ownership.

          (a)  Amount beneficially owned:

               See item (9) of cover pages

          (b)  Percent of Class:

               See item (11) of cover pages

          (c)  Number of shares as to which such person has:

               (i)    sole power to vote or to direct the vote:



                                       3


                      See item (5) of cover pages

               (ii)   shared power to vote or to direct the vote:

                      See item (6) of cover pages

               (iii)  sole power to dispose or to direct the disposition of:

                      See item (7) of cover pages

               (iv)   shared power to dispose or to direct the disposition of:

                      See item (8) of cover pages

Item 5.  Ownership of Five Percent or Less of a Class:

         Not applicable.

Item 6.  Ownership of More than Five Percent on Behalf of Another Person:

         Not applicable

Item 7.  Identification  and Classification of the Subsidiary Which Acquired the
         Security Being Reported on By the Parent Holding Company or Control
         Person:

         Not applicable

Item 8.  Identification and Classification of Members of the Group:

         Not applicable

Item 9.  Notice of Dissolution of Group:

         Not applicable

Item 10. Certification:

         Not applicable


                                       4





                                    SIGNATURE

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.

                                        2-14-01
                                        _______________________________________
                                                       (Date)

                                        /s/ Steven G. Anderson
                                        _______________________________________
                                                     (Signature)

                                        Steven G. Anderson
                                        _______________________________________
                                                     (Name/Title)

                                       6